跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Latrela - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Latrela
Approved
STANDARD
Latrela
Takeda Pharmaceutical Company Limited (Osaka Plant)
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
5d7fc7befd668d9d
Company
Takeda Pharmaceutical Company Limited (Osaka Plant)
Type
Standard
Approval Details
Approval Id
5d7fc7befd668d9d
Drug Approval Philippines Name
Latrela
Product Name
Latrela
Registration Number
DR-XY47110
Brand Name
Latrela
Generic Name
Trelagliptin (as succinate)
Dosage Form
Film-Coated Tablet
Dosage Strength
100mg
Manufacturer
Takeda Pharmaceutical Company Limited (Osaka Plant)
Importer
Takeda Healthcare Philippines, Inc.
Issuance Date
27 November 2020
Expiry Date
27 November 2025
Pharmacologic Category
Anti-Diabetes
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
5d7fc7befd668d9d
Type
Standard
Back to Philippines FDA Approvals